Dendritic cells in uninfected infants born to hepatitis B virus-positive mothers.
Plasmacytoid dendritic cells (pDCs) play a central role in antiviral immunity, detecting viruses via Toll-like receptors (TLR) and producing in response vast amounts of type I interferons (IFNs). Hepatitis B virus (HBV) causes chronic infection after vertical transmission. This study investigated whether an HBV-infected maternal environment might influence DC numbers and pDC function in uninfected infants. Blood was collected from inactive HBsAg carrier and control mothers and their infants at birth and 1 and 6 months of age. HBV DNA was measured in maternal and neonatal perinatal sera using real-time PCR. The circulating frequencies of myeloid DCs (mDCs) and pDCs were determined in the babies by flow cytometry. Peripheral blood mononuclear cells (PBMCs) and cord blood pDCs were stimulated with resiquimod, and alpha interferon (IFN-alpha) production and the pDC phenotype were assessed. The effect of the common-cold virus, rhinovirus (RV), on resiquimod stimulation was also determined. HBV DNA was detected in 62.3% of the mothers and 41% of their infants. DC numbers and pDC functions were similar between subjects and controls and were not correlated with maternal or neonatal viremia. RV infection did not induce pDC maturation until the age of 6 months, and it reduced TLR7-dependent resiquimod-induced IFN-alpha production similarly in both groups. Although the DC system is immature at birth, DCs of uninfected neonates of HBV-positive mothers are competent to initiate and maintain T-cell responses. RV is a weak inducer of IFN-alpha production until the age of 6 months and inhibits IFN-alpha responses triggered by the TLR7 pathway.
Koumbi
Lemonica J
LJ
Alzaia Naviglio Pavese 8, 21036 Milan, Italy. lemonica.koumbi@gmail.com
Papadopoulos
Nikolaos G
NG
Anastassiadou
Vassiliki
V
Machaira
Maria
M
Kafetzis
Dimitris A
DA
Papaevangelou
Vassiliki
V
D000328:Adult; D016022:Case-Control Studies; D003713:Dendritic Cells / Q000276:immunology*; D005260:Female; D005434:Flow Cytometry; D006509:Hepatitis B / Q000276:immunology / Q000635:transmission; D006515:Hepatitis B virus / Q000276:immunology*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008431:Maternal-Fetal Exchange / Q000276:immunology*; D009035:Mothers; D011247:Pregnancy; D014766:Viremia
D007093:Imidazoles; C402365:resiquimod
Thorax. 1998 Nov;53(11):913-4
10193386
Hepatology. 2003 Nov;38(5):1075-86
14578844
J Gastroenterol Hepatol. 2005 Feb;20(2):234-42
15683426
Am J Respir Crit Care Med. 2005 Oct 15;172(8):1037-40
15994468
Science. 1999 Jun 11;284(5421):1835-7
10364556
Hum Immunol. 2002 Dec;63(12):1103-10
12480253
Am J Epidemiol. 1983 Feb;117(2):213-22
6402925
Blood. 2004 Feb 1;103(3):1030-2
14504106
Clin Exp Allergy. 2002 Apr;32(4):537-42
11972599
Allergy. 2009 Mar;64(3):375-86
19175599
Cell Immunol. 2002 Jul-Aug;218(1-2):74-86
12470615
Chin Med J (Engl). 2002 Sep;115(9):1380-2
12411117
J Infect Dis. 1985 Apr;151(4):599-603
3973412
J Clin Immunol. 2004 Nov;24(6):637-46
15622448
J Immunol. 2009 Oct 1;183(7):4440-8
19734213
Vaccine. 1998 Aug-Sep;16(14-15):1415-9
9711781
Clin Immunol. 2006 Dec;121(3):251-9
17010668
J Virol Methods. 2002 May 16;103(2):201-12
12008014
Proc Natl Acad Sci U S A. 1990 Sep;87(17):6599-603
2395863
Pathol Biol (Paris). 2002 Nov;50(9):568-75
12490422
Eur J Immunol. 2001 Oct;31(10):3026-37
11592079
J Virol. 2005 May;79(9):5507-15
15827165
Clin Immunol. 2008 Mar;126(3):243-50
18201932
Blood. 1994 Dec 15;84(12):4333-43
7994049
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5598-603
15034168
Science. 2004 Mar 5;303(5663):1529-31
14976261
Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10006-10
1438190
Immunol Cell Biol. 2005 Oct;83(5):571-7
16174109
J Immunol. 2004 Nov 15;173(10):5935-43
15528327
J Hepatol. 2007 Dec;47(6):751-9
17920718